Follicular Lymphoma: On the Road to Cure Educational Symposium
Hope for Lymphoma, Rush University Cancer Center, and Rush University Medical Center commemorated World Lymphoma Awareness Day by hosting the “Follicular Lymphoma: On the Road to Cure” Educational Symposium on September 15th. The symposium, chaired by Dr. Stephanie Gregory, originated from Chicago and featured seven world leading lymphoma experts. Presentations and panel discussions covered the follicular lymphoma waterfront – providing basic and advanced information about the disease as well as current treatment options and novel and emerging treatments. Patients’ probing questions received insightful and detailed responses from the faculty.areceived a comprehensive set of written materials on follicular lymphoma. In addition, those who attended at Rush received copies of the latest edition of our “Battling and Beating Cancer – The Cancer Survival Book”
More than 30,000 people participated remotely from all across the globe by web, computer, mobile applications, social media and through the broadcast on the "Battling and Beating Cancer" Radio Show on the Blog Talk Radio Network. The symposium was aired on CAN TV in Chicago.
Thanks to our sponsors, particularly Teva Oncology and Celgene Corporation, for providing support through unrestricted educational grants.
Special thanks to Dr. Gregory for chairing the symposium and to our presenters Dr. Kahl, Dr. Rummel, Dr. Flowers, Dr. Schuster, Dr. Venugopal, Dr. Fung, Dr. Nathan, Dr. Gauthier, and Ms. de Parry. Thanks to all of the nurses, patients, and caregivers who participated. .
PRESENTATIONS AND PANEL DISCUSSIONS
Welcoming and introductory remarks from Scott Seaman, Dr. Howard Kaufman, Director of Rush University Cancer Center, and conference chair Dr. Stephanie Gregory, The Elodia Kehm Chair of Hematology, Rush University Medical Center and Rush University Cancer Center.
“Follicular Lymphoma Basics; Advances in First Line Treatment and Management of Asymptomatic and/or Low Tumor Burden Disease” and features Dr. Brad S. Kahl, Director of Lymphoma Service and Clinical Research Director for Hematologic Malignancies for the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center.
“Management of Symptomatic, High Tumor Burden or Bulky Disease; and What to do if Chemo isn’t Working (So That’s What Refractory Means)” and features Dr. Mathias J. Rummel, Head of the Department of Hematology at the Clinic for Hematology and Medical Oncology at the Justus-Liebig University-Hospital, Gielsen, Germany and founder of the STiL (The German Study Group for Indolent Lymphomas).
Panel discussion entitled “Is Watch & Wait Out of Date? What Early Treatments Should be Considered? Is Rituximab Maintenance for Everyone?” and answers various questions from patient participants. Conference chair Dr. Stephanie Gregory (Elodia Kehm Chair of Hematology, Rush University Medical Center, Rush University Cancer Center) leads the discussion that features Dr. Parmeswaran Venugopal (Rush University Medical Center), Dr. Brad Kahl (University of Wisconsin Paul P. Carbone Comprehensive Cancer Center), Dr. Mathias Rummel (Justus-Liebig University-Hospital, Gielsen, Germany), and Dr. Stephen Schuster (Perelman Center for Advanced Medicine, The University of Pennsylvania Health System).
“Latest Options for Relapse” and features Dr. Christopher R. Flowers, Director Lymphoma Program at Emory University’s Winship Cancer Institute and Associate Professor, Bone Marrow and Stem Cell Transplantation at Emory University School of Medicine.
A panel discussion entitled “Progress in Stem Cell Transplants: Curative for Some Patients, Now How Might We Cure More? Conference chair Dr. Stephanie Gregory (Elodia Kehm Chair of Hematology, Rush University Medical Center, Rush University Cancer Center) leads the discussion that features Dr. Christopher R. Flowers (Emory Universitys Winship Cancer Institute), Dr. Henry Fung (Rush University Medical Center), and Dr. Sunita Nathan (Rush University Medical Center).
“How Close Are We To Cure? The Most Exciting Novel and Emerging Treatments in the Pipeline” and features Dr. Stephen J. Schuster, Director, Lymphoma Program and Director of Translational Research, Abramson Cancer Center, the Perelman Center for Advanced Medicine, The University of Pennsylvania Health System.
A panel discussion entitled “The Road Ahead: Managing Follicular Lymphoma For Long Term, Optimum Survivorship. Conference chair Dr. Stephanie Gregory (Elodia Kehm Chair of Hematology, RushUniversityMedicalCenter, RushUniversityCancerCenter) leads the discussion that features various faculty members including Dr. Janine E. Gauthier, Director Clinical Services, Cancer Integrative Medicine Program, and Director of Psychosocial Services, RushUniversityMedicalCenter, and lymphoma survivor and author Betsy de Parry. The panel also answer questions from patient participants on RIT and other topics.
Battling And Beating Cancer Cancer Research Is The Superhighway To Curing Cancer
Website created by Charlene McMann-Seaman and Scott Seaman
